
A digital twin for the body: why patient data consent is vital
Data gathered from numerous digital touchpoints and interactions may create a complete digital twin for the human body in the…
Data gathered from numerous digital touchpoints and interactions may create a complete digital twin for the human body in the…
Despite industry investment in large molecule drugs, demand for small molecule active pharmaceutical ingredients (API) manufacturing remains high. Driven by…
In the wake of Russia’s invasion of Ukraine, sponsors are increasingly evaluating other European countries to conduct their clinical trials.…
Approximately 75,000 enzymes are thought to exist in the human body as vital catalysts for biochemical reactions or conversions. For…
Each molecule has unique requirements and challenges, and a variety of solutions for drug substance synthesis and manufacturing are available,…
The global healthcare and pharmaceutical industry is frequently faced with having to find new ways of innovating and carrying out…
In 2022, there is still significant demand for small molecule API manufacturing. GlobalData’s Drugs database indicates that 97% of marketed…
The integration of Internet of Things (IoT) technology across the pharmaceutical supply chain has allowed for greater visibility and traceability…
Thank you for subscribing to Pharmaceutical Technology